COMP <GO>
TGEN vs TMO // 10Y YIELD & FRED MACRO BETA
Tecogen Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: TGEN 1
— TMO 9
■ METRIC PARITY
LAST: $1.99 (-14.59%) • MKT CAP: $70.3M
macro-sensitivity
—
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
macro-sensitivity
0.94
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TGEN VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TGEN | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 9.30% | -44.30 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -14.66% | 2.40% | -17.06 | TMO | /fcf-yield <GO> |
| Operating Margin | -30.50% | 17.40% | -47.90 | TMO | /operating-margins <GO> |
| Net Profit Margin | -30.50% | 15.10% | -45.60 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 19.70% | 3.90% | +15.80 | TGEN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.24 | 4.50 | -3.26 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.9 | 62.9 | -27.00 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $70.3M | $262.22B | -$262.15B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TGEN REV | TMO REV | TGEN GROSS % | TMO GROSS % | TGEN FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $27.1M | $44.56B | 36.3% | — | -$10.3M | $6.29B |
| FY 2024 | $22.6M | $42.88B | 43.6% | — | $3.1M | $7.27B |
| FY 2023 | $25.1M | $42.86B | — | — | -$817.8K | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TGEN // BETA —
TMO // BETA 0.94